You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華潤三九(000999.SZ):公司將持續構建產業鏈能力
格隆匯 07-04 16:00

格隆匯7月4日丨有投資者向華潤三九(000999.SZ)提問:配方顆粒業務未來趨勢和競爭情況?公司的規劃是什麼?

華潤三九回覆:隨着配方顆粒生產廠家逐漸增多,在監管嚴格的態勢下配方顆粒業務將進行有序競爭;配方顆粒業務較複雜,品種數量多,對企業全產業鏈的管理能力要求較高,從前端藥材資源、生產環節到銷售服務,都需要較大的投入和管理能力。地方企業生產符合當地標準的產品進行推廣銷售,有一定優勢。長期來看,隨着國標品種不斷頒佈實施,總體認為全國性企業會有比較好產業鏈管理和成本優勢,主要在於全國性企業以往研發和生產基礎較強,質量控制和全產業鏈管理基礎較好,有一定的先發優勢。公司將持續構建產業鏈能力,實現全產業鏈均衡發展,在競爭中取得優勢。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account